Theravance Biopharma Inc. Insider Trading

TBPH

Last 12 months

Insiders sold $2.86M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in May 2018.

Net open-market

−$2.86M

0 buys · 6 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

May 2018

May 21, 2018

Get an email when TBPH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 15	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan 3 parts	13,314	$17.03 average	227K	5.9%	Form 4
Jul 6 – 7	Eli Samaha Large holder	SoldNo plan 2 parts	6,964	$17.14 average	119K	<0.1%	Form 4
Jun 29 – Jul 1	Eli Samaha Large holder	SoldNo plan 3 parts	336,697	$17.20 average	$5.79M	3.5%	Form 4
Jun 15	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan 3 parts	13,314	$16.39 average	218K	5.4%	Form 4
Mar 16	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan 3 parts	31,067	$13.96 average	434K	12%	Form 4
Dec 3, 2025	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan 3 parts	31,067	$18.75 average	583K	10%	Form 4
Nov 26, 2025	Eran Broshy Director	Sold10b5-1 plan 2 parts	29,501	$20.00 average	590K	40%	Form 4
Nov 11, 2025	Eran Broshy Director	Sold10b5-1 plan 3 parts	45,000	$17.98 average	809K	43%	Form 4
Jul 14, 2025	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan 3 parts	10,000	$11.39 average	114K	3.0%	Form 4
Jun 2, 2025	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan	24,000	$11.00	264K	6.6%	Form 4
Apr 21, 2025	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan	4,000	$9.00	36K	1.1%	Form 4
Jan 21, 2025	Rhonda Farnum SVP, Comm & Medical Affairs	Sold10b5-1 plan	4,000	$9.00	36K	1.3%	Form 4
Nov 11, 2024	Rhonda Farnum SVP, Comm & Medical Affairs	SoldNo plan	4,000	$9.00	36K	1.2%	Form 4

Sep 1510b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 13,314 at avg $17.03
227K
5.9% of stake
Jul 6 – 7No plan
Eli Samaha
Large holder · sold 6,964 at avg $17.14
119K
<0.1% of stake
Jun 29 – Jul 1No plan
Eli Samaha
Large holder · sold 336,697 at avg $17.20
$5.79M
3.5% of stake
Jun 1510b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 13,314 at avg $16.39
218K
5.4% of stake
Mar 1610b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 31,067 at avg $13.96
434K
12% of stake
Dec 3, 202510b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 31,067 at avg $18.75
583K
10% of stake
Nov 26, 202510b5-1 plan
Eran Broshy
Director · sold 29,501 at avg $20.00
590K
40% of stake
Nov 11, 202510b5-1 plan
Eran Broshy
Director · sold 45,000 at avg $17.98
809K
43% of stake
Jul 14, 202510b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 10,000 at avg $11.39
114K
3.0% of stake
Jun 2, 202510b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 24,000 at $11.00
264K
6.6% of stake
Apr 21, 202510b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 4,000 at $9.00
36K
1.1% of stake
Jan 21, 202510b5-1 plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 4,000 at $9.00
36K
1.3% of stake
Nov 11, 2024No plan
Rhonda Farnum
SVP, Comm & Medical Affairs · sold 4,000 at $9.00
36K
1.2% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TBPH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with TBPH

CompareIntrinsic value

XNCRXencor Inc.

$35.01+14.28%0

LFCRLifecore Biomedical, Inc.

$6.44+0.31%0

ETONEton Pharmaceuticals Inc.

$50.72-0.45%75

ASRTAssertio Holdings Inc.

$9.09+0.28%10

SEPNSepterna, Inc.

$47.88+9.57%46

AGIOAgios Pharmaceuticals Inc.

$31.38+0.58%40

GYREGyre Therapeutics Inc.

$4.44+0.00%18

SPRYArs Pharmaceuticals Inc

$3.05+0.00%40

Spot a number that looks wrong? Check it in TBPH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TBPH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.